Brief: ChemoCentryx Posts Quarterly Loss Per Share $0.35
Nov 9 (Reuters) - ChemoCentryx Inc CCXI.O :
* CHEMOCENTRYX REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
AND
RECENT HIGHLIGHTS
* Q3 REVENUE $5.1 MILLION VERSUS $10.6 MILLION
* Q3 REVENUE ESTIMATE $10.7 MILLION -- REFINITIV IBES DATA
* QTRLY LOSS PER SHARE $0.35
Source text for Eikon: ID:nGNX24q8X7
Further company coverage: CCXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Churchill Capital XI
See all newsBrief: AGCO To Pilot Digit Humanoid Robot At Hesston, Kansas Facility In 2027
Brief: Agility Robotics Announces Audit Committee Chair For Planned Public-Company Board
Brief: Agility Robotics And Churchill Capital Corp Xi S-4 Registration Statement Declared Effective By SEC In Connection With Proposed Business Combination
Brief: Agility And Fort Robotics Announce Strategic Partnership To Advance Humanoid Robot Safety
Deals of the day-Mergers and acquisitions